(A-A”) Simultaneous detection of SOX9, glucagon and GFP in Sox9-eGFP mice and subsequent confocal analysis shows almost complete overlap of GFP and SOX9 expression in the dorsal pancreatic bud at e10.5. While most glucagon+ cells do not express SOX9 (A’, arrowheads in inset), occasional SOX9/glucagon coexpressing cells are detected (A’, arrow in inset). All glucagon+ cells express GFP (A”, arrow and arrowheads). Staining of sections from Sox9-eGFP mice for E-cadherin reveals that the GFP signal is restricted to the epithelial progenitor cords at e15.5 (C). (B-B”) Simultaneous detection of SOX9, NGN3 and GFP at e15.5 shows that the majority of the SOX9+/GFP+ cells do not express NGN3 (B,B’, yellow arrowheads), while a small proportion of the SOX9+ cells also express NGN3 (B’, white arrows). Notably, a subset of NGN3+ cells shows no SOX9 expression but retains GFP label (B’,B”, white arrowheads), suggesting that NGN3+ cells arise from the SOX9+ domain. Also, at e15.5, GFP co-localizes with insulin (D, arrows) and glucagon (D, arrowheads) as well as amylase (D, arrows). Since SOX9 protein is absent from endocrine and exocrine cells at e15.5, this indicates that both lineages originate from SOX9+ cells. (F-F”) Simultaneous detection of SOX9, NGN3 and GFP at e17.5 shows that NGN3+ cells continue to arise from SOX9+ progenitors late in embryogenesis. Note the NGN3+/SOX9− cells that are GFP+ (F’,F”, arrowheads). The arrow (F’,F”) points to a cell that expresses SOX9, NGN3 and GFP. At e18.5, GFP co-localizes with SOX9 in the pancreatic ducts (G). GFP label continues to be seen in a proportion of insulin+ (H, arrows) and glucagon+ cells (H, arrowheads). However, amylase+ cells no longer retain GFP at e18.5 (I), suggesting that endocrine, but not exocrine cells, continue to arise from SOX9+ progenitors until birth. Note that the SOX9 signal was digitally color-converted in A-A’, B-B” and F-F”. INS, insulin; GLU, glucagon; AMY, amylase; E-CAD, E-cadherin. Scale bar = 50µm in A–B and D–I; 100µm in C.